Pharsight

ADS THERAPEUTICS PATENTS FACING OPPOSITIONS

Top patents of ADS THERAPEUTICS facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP3463315B1 14 Jun, 2023 Compositions And Methods Of Using Nintedanib For Treating Ocular Diseases With Abnormal Neovascularization NA 1